Search for: "Teva Pharmaceuticals" Results 281 - 300 of 1,423
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Mar 2019, 5:45 am by Patrick Eckerd
The settlement is by far the largest among settlements paid by pharmaceutical companies in similar suits brought by states. [read post]
27 Mar 2019, 5:58 am by Sara E. Teller
Two other defendants remain, Johnson & Johnson and Teva Pharmaceuticals. [read post]
11 Mar 2019, 10:15 am by Scott Sternberg
By: Amber Barlow Garcia, Deutsch KerriganWhen a lawsuit is filed in state court but federal court is a proper forum, defendants often prefer to remove the case. [read post]
31 Jan 2019, 8:32 am
TEVA Pharmaceuticals USA INC., et al.,  had the opportunity to interpret the Leahy-Smith America Invents Act (AIA) with respect to how this impacts on the issue of the novelty of an invention. [read post]
30 Jan 2019, 5:06 am by Sara E. Teller
Besides Purdue Pharma LP, the list of defendants named in NYC’s suit includes long-time opioid manufacturers Allergan Plc, Endo International Plc, Johnson & Johnson, and Teva Pharmaceutical Industries Ltd., and distributors AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp. [read post]
29 Jan 2019, 9:17 am by Jim Singer
Teva Pharmaceuticals USA, Inc., the Court considered agreements by which the patent holder (Helsinn) agreed to license and sell palonosetron, which is the active ingredient a drug that treats chemotherapy-induced nausea. [read post]
29 Jan 2019, 6:32 am by Andrew Hamm
Teva Pharmaceuticals USA Inc., in which the court held that the sale of an invention to a third party who is obligated to keep the invention confidential may place the invention “on sale” for purposes of the Leahy-Smith America Invents Act. [read post]
28 Jan 2019, 7:17 am by Andrew Hamm
Teva Pharmaceuticals USA Inc., in which the court held that the sale of an invention to a third party who is obligated to keep the invention confidential may place the invention “on sale” for purposes of the Leahy-Smith America Invents Act. [read post]
24 Jan 2019, 4:14 am by Edith Roberts
Teva Pharmaceuticals, in which the court held that an invention is “on sale,” and therefore cannot be patented, if the inventor made a “secret sale” of the invention before seeking a patent. [read post]
23 Jan 2019, 10:00 pm
Teva Pharmaceuticals USA Inc., No. 17-1229 (2019). [read post]
23 Jan 2019, 12:24 pm by Stephanie Sundier
Teva Pharmaceuticals wanted to market a generic palonosetron product in 2011. [read post]
23 Jan 2019, 4:07 am by Edith Roberts
Teva Pharmaceuticals, that an invention is “on sale,” and therefore cannot be patented, if the inventor made a private sale of the invention before seeking a patent. [read post]